Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01153035
NA

Excision Followed by Radiofrequency Ablation for Breast Cancer

Sponsor: University of Arkansas

View on ClinicalTrials.gov

Summary

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.

Official title: ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer

Key Details

Gender

FEMALE

Age Range

50 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

104

Start Date

2010-06

Completion Date

2027-06

Last Updated

2025-11-10

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Radiofrequency Ablation

Breast conservation surgery followed by Radiofrequency Ablation of the cavity

Locations (6)

University of Arizona

Tucson, Arizona, United States

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States

Sharp Oncology (Comprehensive Breast Care of San Diego)

San Diego, California, United States

Comprehensive Breast Care of Denver

Denver, Colorado, United States

The University of Kansas Cancer Center

Westwood, Kansas, United States

Columbia

New York, New York, United States